DRTS
NASD Alpha Tau Medical Ltd$12.72 ↑ +0.10 (+0.79%) Trading Up from the previous close of $12.62
- YTD change
- +156.97%
- vs 20-day SMA
- -10.73%
- vs 200-day SMA
- +23.67%
Price ranges
Price & Performance
+4.51 (+55.61%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 38.4% away from all-time highs of $20.65
- DRTS is up 157% since the beginning of the year
- DRTS is up 218% over the past 12 months
- DRTS is down 18% over the past 1 month
- 5% of all DRTS investors are betting against DRTS
DRTS reads neutral: price sits above one of the two key moving averages, the 12-month move is +215.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.15
- Last 5 days
- -10.80%
- vs 8-day SMA
- -5.76%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.